High value intervention in atrial fibrillation

The information below relates to the CVD prevention pathway.

  • Undertake systematic audit across practices (GRASP-AF audit tool and the Warfarin Patient Safety Tool).
    • Identify people with possible undiagnosed AF.
    • Identify people with AF at high risk of stroke who are not anticoagulated or not maintained in the therapeutic range.
  • Work with practices and local authorities to maximise NHS Health Check uptake and follow up.
  • Build local primary care leadership to challenge unwarranted variation and drive quality improvement in detection and management.
  • Add pulse checking to existing GP and pharmacy enhanced services for people over 65.
  • Agree local clinical consensus and pathway for anticoagulation including the place of novel oral anticoagulants (NOACs).
  • Consider commissioning:
    • Technologies such as WatchBP Home A and AliveCor to support AF detection in routine care.
    • New models of anticoagulation control eg self-monitoring and community pharmacy monitoring
    • Systematic support for adherence from community pharmacists.

Further information

Return to the CVD prevention pathway.